XML 37 R19.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK-BASED COMPENSATION
12 Months Ended
Apr. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
STOCK-BASED COMPENSATION
12.
STOCK-BASED COMPENSATION
 
Equity Incentive Plan Description

On September 16, 2015, our shareholders approved an equity incentive plan entitled the Culp, Inc. 2015 Equity Incentive Plan (the “2015 Plan”). The 2015 Plan is intended to update and replace our 2007 Equity Incentive Plan (the “2007 Plan”) as the vehicle for granting new equity based awards substantially similar to those authorized under the 2007 Plan. In general, the 2015 Plan authorizes the grant of stock options intended to qualify as incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance units, and other equity and cash related awards as determined by our Compensation Committee. An aggregate of 1,200,000 shares of common stock were authorized for issuance under the 2015 Plan, with certain sub-limits that would apply with respect to specific types of awards that may be issued as defined in the 2015 Plan. In connection with the approval of the 2015 Plan, no further awards will be granted under the 2007 Plan, but outstanding awards under the 2007 Plan will be settled in accordance with their terms.

At April 30, 2017, there were 964,494 shares available for future equity based grants under the company’s 2015 Plan.

Stock Options

Under our 2007 Plan, employees, outside directors, and others associated with the company were granted options to purchase shares of common stock at the fair market value on the date of grant.

No compensation expense was recorded for incentive or non-qualified stock options in fiscal 2017, 2016 and 2015 as all stock option awards were fully vested at the end of fiscal 2014.
 
The following tables summarize stock option activity for fiscal 2017, 2016, and 2015:

         
2017
         
2016
         
2015
 
            Weighted-            Weighted-           Weighted-  
         
Average
         
Average
         
Average
 
           
Exercise
         
Exercise
         
Exercise
 
   
Shares
   
Price
   
Shares
   
Price
   
Shares
   
Price
 
outstanding at beginning
                                   
of year
   
83,600
   
$
8.37
     
140,100
   
$
6.49
     
153,950
   
$
6.70
 
granted
   
-
     
-
     
-
     
-
     
-
     
-
 
exercised
   
(68,000
)
   
8.65
     
(54,500
)
   
3.68
     
(10,100
)
   
9.31
 
canceled/expired
   
-
     
-
     
(2,000
)
   
4.59
     
(3,750
)
   
7.27
 
outstanding at end of year
   
15,600
     
7.14
     
83,600
     
8.37
     
140,100
     
6.49
 
 
 
   
Options Outstanding
   
Options Exercisable
 
 
Range of
 
Number
Outstanding
    Weighted-Avg.
Remaining
    Weighted-Avg.    
Number
Exercisable
    Weighted-Avg.  
Exercise Prices
 
at 4/30/17
    Contractual Life     Exercise Price    
at 4/30/17
    Exercise Price  
$7.08 - $8.75
   
15,600
      1.1     $ 7.14      
15,600
    $ 7.14  
 
At April 30, 2017, the aggregate intrinsic value for options outstanding and exercisable was $389,000.

The aggregate intrinsic value for options exercised was $1.7 million, $1.3 million, and $87,000 in fiscal 2017, 2016, and 2015, respectively.

At April 30, 2017, there were no unvested incentive stock option awards. Therefore, there was no unrecognized compensation cost related to the incentive stock option awards at April 30, 2017.

Time Vested Restricted Stock Awards
 
On July 14, 2016, an employee was granted 1,200 shares of time vested restricted common stock units. This award was valued based on the fair market value on the date of grant. The fair value of this award was $28 per share, which represents the closing price of our common stock on the date of grant. The vesting of this award was is over the requisite service period of 11 months.
 
The following table summarizes the time vested restricted stock activity for fiscal years 2017, 2016, and 2015:

   
2017
Shares
   
2016
Shares
   
2015
Shares
 
outstanding at beginning of year
   
-
     
-
     
61,668
 
granted     1,200       -       -  
vested    
-
     
-
      (61,668 )
outstanding at end of year
   
1,200
     
-
     
-
 
 
During fiscal 2015, 61,668 shares of time vested restricted stock vested and had a weighted average fair value of $257,000 or $4.17 per share.

At April 30, 2017, the remaining unrecognized compensation cost related to our time vested restricted common stock units was $5,000, which is expected to be recognized over the next 1.5 months.

We recorded compensation expense of $29,000 and $4,000 within selling, general, and administrative expense for time vested restricted stock units in fiscal 2017 and 2015, respectively. No compensation expense was recorded for time vested restricted stock awards in fiscal 2016 as all time vested restricted stock awards granted prior to fiscal 2016 were fully vested at the end of fiscal 2015.

Performance Based Restricted Stock Units

We have granted performance based restricted stock units to certain key members of management and a non-employee which could earn up to a certain number of shares of common stock if certain performance targets are met as defined in the related restricted stock unit agreements. Our performance based restricted stock units granted to key members of management were measured based on the fair market value (the closing price of our common stock) on the date of grant. Our performance based restricted stock units granted to a non-employee were measured based on the fair market value (the closing price of our common stock) at the earlier date of when the performance criteria are met or the end of the reporting period.
 
The following table summarizes information related to our grants of performance based restricted stock units associated with key members of management for fiscal years 2017, 2016, and 2015:

   
(1)
Restricted Stock
   
(2)
Price Per
 
 
Vesting
Date of Grant
 
Units Awarded
   
Share
 
Period
July 14, 2016
   
107,880
   
$
28.00
 
3 years
July 15, 2015
   
107,554
   
$
32.23
 
3 years
June 24, 2014
   
102,845
   
$
17.70
 
3 years
 
(1) Amounts represent the maximum number of common stock shares that could be earned if certain performance targets are met as defined in the related restricted stock unit agreements.
 
(2) Price per share represents the closing price of our common stock on the date of grant.
 
The following table summarizes information related to our grants of performance based restricted stock units associated with a non-employee for fiscal years 2017, 2016, and 2015:

 
Date of Grant
 
(1)
Restricted Stock
Units Awarded
   
(2)
Price Per
Share
 
Vesting
Period
July 14, 2016
   
11,549
   
$
32.10
(2)
3 years
July 15, 2015
   
10,364
   
$
32.10
(2)
3 years
March 3, 2015
   
16,000
   
$
32.10
(2)
28 months
March 3, 2015
   
12,000
   
$
28.77
(3)
16 months
 
(1) Amounts represent the maximum number of common stock shares that could be earned if certain performance targets are met as defined in the related restricted stock unit agreements.

(2) The respective grant was unvested at the end of our reporting period. Accordingly, the price per share represents the closing price of our common stock on April 30, 2017, the end of our reporting period.

(3) The respective grant vested during the first quarter of fiscal 2017. Accordingly, the price per share represents the closing price of our common stock on the date the award vested.
 
The following table summarizes information related to our performance based restricted stock units that vested during fiscal years 2017 and 2016. No performance based restricted stock units vested during fiscal 2015:

 
Fiscal Year
 
Common Stock
Shares Vested
   
(1)
Weighted Average
Fair Value
   
Price
Per Share
 
Fiscal 2017 - Management
   
37,192
   
$
637
   
$
17.12
(2)
Fiscal 2017 - Non-Employee
   
12,000
   
$
345
   
$
28.77
(3)
Fiscal 2016 - Management
   
115,855
   
$
1,183
   
$
10.21
(2)
 
(1) Dollar amounts are in thousands.

(2) Price per share represents the closing price of our common stock on the date of grant.

(3) The respective grant vested during the first quarter of fiscal 2017. Accordingly, the price per share represents the closing price of our common stock on the date the award vested.

Overall

We recorded compensation expense of $3.2 million, $2.6 million, and $727,000 within selling, general, and administrative expense for performance based restricted stock units in fiscal 2017, 2016 and 2015, respectively. Compensation cost is recorded based on an assessment each reporting period of the probability that certain performance goals will be met during the vesting period. If performance goals are not probable of occurrence, no compensation cost will be recognized and any recognized compensation cost would be reversed.

At April 30, 2017, the remaining unrecognized compensation cost related to the performance based restricted stock units was $3.9 million, which is expected to be recognized over a weighted average vesting period of 1.7 years.

Common Stock Awards

We granted a total of 4,800, 3,000, and 3,000 shares of common stock to our outside directors on October 3, 2016, October 1, 2015, and October 1, 2014, respectively. These shares of common stock vested immediately and were valued based on the fair market value on the date of grant. The fair value of these awards were $29.80, $31.77, and $17.95 per share, on October 3, 2016, October 1, 2015, and October 1, 2014, which represents the closing price of our common stock on the date of grant.

We recorded $143,000, $95,000, and $55,000, of compensation expense within selling, general, and administrative expense for these common stock awards for fiscal 2017, 2016, and 2015, respectively.